Dr. Suárez-Calvet has a degree in Medicine (UAB) and Biochemistry (UB), specializing in Neurology at the Hospital de la Santa Creu i Sant Pau in Barcelona and earned a PhD cum laude from the Universitat Autònoma de Barcelona (UAB). He joined the BarcelonaBeta Brain Research Center in 2018 where he led research on new blood biomarkers in neurodegenerative diseases, in collaboration with the Sahlgrenska Academy (University of Gothenburg), thanks to a grant from the Marie Sklodowkska-Curie Fellowship program. In addition, in 2020, the European Research Council (ERC) awarded him an ERC Starting Grant to lead the HeBe project.

He previously worked as a researcher in the Department of Biochemistry at the University of Munich and at the Dementia Research Center at University College London. Throughout his career he has combined clinical experience with intense activity as a basic researcher, as demonstrated by publications in high-impact journals such as Science Translational Medicine, EMBO Molecular Medicine, Acta Neuropathologica or Neuron.
In addition to his research work at the BarcelonaBeta Brain Research Center, Dr. Suárez-Calvet is a clinical neurologist at the Hospital del Mar (Barcelona), specializing in Alzheimer’s disease and other neurodegenerative diseases.